The p75NTR extracellular domain: A potential molecule regulating the solubility and removal of amyloid-β

Prion

Volumn 5, Issue 3, 2011, Pages 161-163

  Zhou, Xin Fu ^a   Wang, Yan Jiang ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer disease; Amyloid ; Blood brain barrier; Clearance; Extracellular domain; p75NTR

Indexed keywords

AMYLOID BETA PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NEUROTROPHIN RECEPTOR P75;

ALZHEIMER DISEASE; AMYLOID PLAQUE; BLOOD BRAIN BARRIER; ENDOCYTOSIS; ENDOTHELIUM CELL; GENE INACTIVATION; HUMAN; NEURITE; NONHUMAN; NOTE; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENILE PLAQUE; SMOOTH MUSCLE FIBER;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOOD-BRAIN BARRIER; HUMANS; PLAQUE, AMYLOID; RECEPTOR, NERVE GROWTH FACTOR; SOLUBILITY;

EID: 80052790704     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.5.3.16896     Document Type: Note

References (15)

1. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010; 330:1774.
2. Selkoe DJ. Alzheimer's disease: genes, proteins and therapy. Physiol Rev 2001; 81:741-66. (Pubitemid 32267077)
3. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256:184-5.
4. Wang YJ, Zhou HD, Zhou XF. Clearance of amyloidbeta in Alzheimer's disease: progress, problems and perspectives. Drug Discov Today 2006; 11:931-8.
5. Blennow K, Zetterberg H. Cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis 2009; 18:413-7.
6. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009; 63:287-303.
7. Wang YJ, Wang X, Lu JJ, Li QX, Gao CY, Liu XH, et al. p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain. J Neurosci 2011; 31:2292-304.
8. Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest 1997; 100:2333-40. (Pubitemid 27500157)
9. Weskamp G, Schlondorff J, Lum L, Becherer JD, Kim TW, Saftig P, et al. Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem 2004; 279:4241-9. (Pubitemid 38199011)
10. Chakravarthy B, Gaudet C, Menard M, Atkinson T, Brown L, Laferla FM, et al. Amyloid-beta peptides stimulate the expression of the p75NTR neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alzheimers Dis 2010; 19:915-25.
11. Costantini C, Weindruch R, Della Valle G, Puglielli L. A TrkA to p75NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem J 2005; 391:59-67. (Pubitemid 41445476)
12. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 2000; 106:1489-99. (Pubitemid 32038587)
13. Bronfman FC, Tcherpakov M, Jovin TM, Fainzilber M. Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome. J Neurosci 2003; 23:3209-20. (Pubitemid 36531962)
14. Spuch C, Carro E. The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epithelium. BMC Neurosci 2011; 12:39.
15. Copray S, Kust B, Emmer B, Lin MY, Liem R, Amor S, et al. Deficient p75 low-affinity neurotrophin receptor expression exacerbates experimental allergic encephalomyelitis in C57/BL6 mice. J Neuroimmunol 2004; 148:41-53. (Pubitemid 38229557)